We did not observe serous cancer in the ovaries of our injected p53/Rb1 mice, possibly due to the use of a different conditional Rb1 knockout model from that used in a previous study (which developed serous ovarian cancer) [24]. This evidence concerns the gene TP53 and ovarian serous adenocarcinoma.